NGM NGM Biopharmaceuticals Inc

1.05
-0.07 (-6.25%)
Sep 22 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

NGM Biopharmaceuticals Financial Summary

The current NGM market cap is 86.85M. The company's latest EPS is -1.97 and P/E is -0.53.

Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 108.67M103.54M87.37M77.88M55.33M
Operating Income -4.31M-49.34M-103.83M-120.7M-166.25M
Net Income -493k-42.8M-102.49M-120.34M-162.67M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 246.09M380.4M329.04M402.39M307.4M
Total Liabilities 59.41M49.68M49M66.74M47.84M
Total Equity -108.2M330.72M280.04M335.65M259.56M
Year End December 30 2022 20182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -7.6M-41.17M-83.5M-73.23M-144.44M
Investing 38.73M48.72M-51M-71.65M14.32M
Financing 198k180.75M35.54M149.66M54.23M
Market Cap 86.85M
Price to Earnings Ratio -0.53
Price to Sales Ratio 1.55
Price to Cash Ratio 1.17
Price to Book Ratio 0.33
Dividend Yield -

Share Statistics

Shares Outstanding 82.72M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.14 (11.86%)

Company Info

Company Name NGM Biopharmaceuticals Inc
Address 850 new burton road
dover, delaware 19904
Website https://www.ngmbio.com
Industry pharmaceutical preparations (2834)